Intravenous iron among cystic fibrosis patients.
Z H
ZH
Hoo
M J
MJ
Wildman
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects; D008171:Lung Diseases / Q000139:chemically induced* / Q000276:immunology; D008320:Maltose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D012189:Retrospective Studies
D005290:Ferric Compounds; C522335:ferric carboxymaltose; D008320:Maltose; D007501:Iron